#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Philadelphia chromosome positive Neurodegenerative disorder Hypoxic-ischaemic encephalopathy Chondrosarcoma Lung adenocarcinoma Cystic fibrosis respiratory infection suppression Raynaud's phenomenon Urea cycle disorder Uveitis PIK3CA related overgrowth spectrum B-cell lymphoma refractory Adenocarcinoma pancreas Neuropathic arthropathy Mantle cell lymphoma stage III Oesophageal squamous cell carcinoma stage II More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Basic Information Brain stem glioma – Basic Information Acquired haemophilia Mitochondrial myopathy – Life with Disease Pituitary-dependent Cushing’s syndrome – Trials in Disease Myxofibrosarcoma – Trials in Disease Sjogren’s syndrome – Treatment Medulloblastoma – Life with Disease Cystic fibrosis lung Adrenocortical carcinoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mk-4830 Ubiquinol Felis Domesticus (555) Tamuzimod Acetate Cytisine Benfotiamine Pentosan Polysulfate Sodium Neratinib Ds-2325A Gilteritinib GSKVX000000034794 Irinotecan Db-1303 Benserazide Hydrochloride Baricitinib Pasireotide Atezolizumab LUXDEGALUTAMIDE Stro-002 Copanlisib Dihydrochloride More therapies…

    Learn about Your Condition

    Immunodeficiency Neuropathy peripheral Embolism venous Appendicitis perforated Hodgkin's disease Breast angiosarcoma Osteotomy HIV infection Large cell lung cancer Hypertrophic cardiomyopathy Somatic symptom disorder Fibrous dysplasia of bone Endometrial cancer metastatic Ehlers-Danlos syndrome Gastric cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac sarcoidosis
    Investigated Drugs:
    • Nanobody Against Macrophage Mannose Receptor, Conjugated With 1,4,7-Triazacyclononane-N,N’,N”-Triacetic Acid, Labelled With Gallium Ga-68
    Belgium

  • Study on Improving Sexual Function in Men and Women After Rectal Cancer Treatment Using Tadalafil

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Tadalafil
    Sweden

  • Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Escitalopram Oxalate
    • Naltrexone Hydrochloride
    • Paroxetine
    Poland

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lupus nephritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Mycophenolic Acid
    • Voclosporin
    • Belimumab
    Austria Czechia Denmark France Germany Hungary +7

  • Study on Teprenone for Preventing Atrial Fibrillation After Heart Surgery in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Teprenone
    The Netherlands

  • Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark Finland Norway Sweden
Previous Page
1 … 841 842 843 844 845 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!